STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. CLDI
  4. [EFFECT] Calidi Biotherapeutics, Inc. SEC Filing

[EFFECT] Calidi Biotherapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:30 P.M.
Form: S-1
CIK: 0001855485
Company Name: Calidi Biotherapeutics, Inc.
File Number: 333-288529

Source: View Original Filing on SEC EDGAR

Stock CLDI logo
Calidi Biotherapeutics Inc

NYSE:CLDI

CLDI Rankings

#6306 Ranked by Market Cap
N/A Ranked by Dividends

CLDI Latest News

Nov 17, 2025
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025
Nov 13, 2025
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Nov 10, 2025
Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC
Nov 4, 2025
Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting
Nov 3, 2025
Matica Bio, a CDMO Leader in Oncolytic Virus Manufacturing, Partners with Calidi Biotherapeutics to Advance Calidi's Project Toward IND

CLDI Latest SEC Filings

Nov 13, 2025
[10-Q] Calidi Biotherapeutics, Inc. Quarterly Earnings Report
Nov 13, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event
Nov 10, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event
Oct 31, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event
Oct 24, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event

CLDI Stock Data

10.54M
6.06M
20.25%
4.45%
7.06%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO